ArticleAnnals of gastroenterological surgery2026
Prospective Feasibility Study of Laparoscopic and Robotic Distal Gastrectomy for Advanced Gastric Cancer to Verify the Safety of Surgical Proximal Margins.
Article in Annals of gastroenterological surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ensuring an adequate surgical proximal margin (SPM) is crucial in radical gastrectomy for gastric cancer. However, the lack of tactile feedback in laparoscopic distal gastrectomy (LDG) and robotic distal gastrectomy (RDG) poses challenges in precisely determining tumor boundaries, particularly in advanced gastric cancer, where tumor infiltration may extend beyond endoscopically detectable margins. This single-center prospective study evaluates the safety of SPM in LDG and RDG for advanced gastric cancer. Methods: Patients with cT1N2-3/cT2N0-3/cT3-4aN0 gastric cancer were enrolled. The primary endpoint was the incidence of SPM < 20 mm. The planned sample size was 130, providing 90% power under the hypothesis of an expected incidence of 10% and a threshold of 20%, using an exact binomial test at a 5% one-sided significance level. Results: Between December 2017 and December 2021, 130 eligible patients were enrolled. Among them, 32 (24.6%) underwent RDG, and 5 (3.8%) required conversion to open surgery. The median SPM length was 52 mm (IQR: 40-76 mm). The incidence of SPM < 20 mm was 3.1% (4/130; 95% CI, 0%-6.9%), below the predefined threshold of 20% and predicted value of 10%. Two patients (1.5%) had positive margins. The overall complication rate was 10.4%, with intra-abdominal infectious complications occurring in 3.1%. No Clavien-Dindo grade IVA or higher complications were observed. Conclusions: LDG and RDG can achieve a safe SPM in advanced gastric cancer, with a low incidence of SPM < 20 mm, ensuring a very low risk of positive SPM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.